To hear about similar clinical trials, please enter your email below
Trial Title:
Percutaneous Nephroscopic Treatment of Parapelvic Cysts
NCT ID:
NCT05504512
Condition:
Kidney Stone
Parapelvic Cyst
Kidney Diseases
Recurrence
Conditions: Official terms:
Cysts
Kidney Diseases
Kidney Calculi
Recurrence
Conditions: Keywords:
Parapelvic Cyst
Recurrence
Kidney Diseases
Study type:
Observational
Overall status:
Unknown status
Study design:
Time perspective:
Retrospective
Intervention:
Intervention type:
Other
Intervention name:
No intervention
Description:
No intervention
Arm group label:
Parapelvic cyst
Summary:
Background of the project: The surgical treatment of parapelvic cysts is currently less
researched and there is no gold standard for surgery. Previously, in percutaneous
nephrolithotomy, we found that fenestration and fenestration drainage in the simultaneous
treatment of pararenal pelvis cysts under nephroscopic nephroscopic surgery has clear
curative effect, less trauma, and quicker recovery.
Objective: To clarify the safety, efficacy and long-term efficacy of percutaneous
nephroscopy in the treatment of parapelvic cysts.
Nature: Retrospective case cohort study. Basic research process: Retrospective collection
of cases in our hospital who underwent percutaneous nephroscopy for the treatment of
parapelvic cysts, and comparison of preoperative and postoperative cyst size changes and
long-term efficacy.
Criteria for eligibility:
Study pop:
Patients who have undergone percutaneous nephroscopic surgery for parapelvic cysts
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- Age 18 or older
- Has undergone percutaneous nephroscopic surgery for parapelvic cysts
- Ability to receive study follow-up
Exclusion Criteria:
- Patient refuses or is unable to give consent
Gender:
All
Minimum age:
18 Years
Maximum age:
70 Years
Healthy volunteers:
No
Locations:
Facility:
Name:
Xiangya hospital of central south university
Address:
City:
Changsha
Country:
China
Contact:
Last name:
Hequn Chen, Ph.D
Phone:
13908475808
Email:
chenhequnxy@126.com
Investigator:
Last name:
Hequn Chen, Ph.D
Email:
Principal Investigator
Start date:
November 30, 2022
Completion date:
December 31, 2023
Lead sponsor:
Agency:
Xiangya Hospital of Central South University
Agency class:
Other
Source:
Xiangya Hospital of Central South University
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05504512